Zobrazeno 1 - 10
of 56
pro vyhledávání: '"MESH : Cyclosporine"'
Autor:
Ramos-Casals, M., Brito-Zeron, P., Bombardieri, S., Bootsma, H., De Vita, S., Dorner, T., Fisher, B. A., Gottenberg, J. -E., Hernandez-Molina, G., Kocher, A., Kostov, B., Kruize, A. A., Mandl, T., W. -F., Ng, Retamozo, S., Seror, R., Shoenfeld, Y., Siso-Almirall, A., Tzioufas, A. G., Vitali, C., Bowman, S., EULAR-Sjögren Syndrome Task Force Group: Sebastian A, Mariette X., Saraux, A, Vissink, A, Rasmussen, A, Hofauer, B, Armagan, B, Feijoo-Massó, C, Shiboski, Ch, Baldini, C, Vollenweider, C, Sene, D, Hammenfors, D, Isenberg, D, Danda, D, Bartoloni, E
Publikováno v:
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 2019, 79 (1), pp.3-18. ⟨10.1136/annrheumdis-2019-216114⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2019, 79 (1), pp.3-18. ⟨10.1136/annrheumdis-2019-216114⟩
Universitat Politècnica de Catalunya (UPC)
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 2019, 79 (1), pp.3-18. ⟨10.1136/annrheumdis-2019-216114⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2019, 79 (1), pp.3-18. ⟨10.1136/annrheumdis-2019-216114⟩
International audience; The therapeutic management of Sjögren syndrome (SjS) has not changed substantially in recent decades: treatment decisions remain challenging in clinical practice, without a specific therapeutic target beyond the relief of sym
Autor:
C. Richer, M.-P. Vincent, G. Youcef, François Alhenc-Gelas, Anne Pizard, Elise Belaidi, M. Clemessy, L. Fazal, Ludovic Waeckel, G. Zadigue, Michel Ovize
Publikováno v:
Biochemical Pharmacology
Biochemical Pharmacology, Elsevier, 2015, 94 (1), pp.22-29. ⟨10.1016/j.bcp.2015.01.007⟩
Biochemical Pharmacology, 2015, 94 (1), pp.22-29. ⟨10.1016/j.bcp.2015.01.007⟩
Biochemical Pharmacology, Elsevier, 2015, 94 (1), pp.22-29. ⟨10.1016/j.bcp.2015.01.007⟩
Biochemical Pharmacology, 2015, 94 (1), pp.22-29. ⟨10.1016/j.bcp.2015.01.007⟩
International audience; Clinical and experimental studies suggest that pharmacological postconditioning with Cyclosporin A (CsA) reduces infarct size in cardiac ischemia and reperfusion. CsA interacts with Cyclophilin D (CypD) preventing opening of t
Publikováno v:
Journal of Proteomics
Journal of Proteomics, Elsevier, 2012, 75 (12), pp.3674-87. ⟨10.1016/j.jprot.2012.04.024⟩
Journal of Proteomics, Elsevier, 2012, 75 (12), pp.3674-87. ⟨10.1016/j.jprot.2012.04.024⟩
International audience; Nephrotoxicity is an adverse event that strongly limits the use of the immunosuppressant cyclosporine in solid organ transplantation and the precise molecular mechanisms underlying this toxicity remain unclear. MS-based proteo
Autor:
I. Pommepuy, P. Piver, Marie Essig, L. Fourcade, T. Gauthier, Y. Aubard, C. Couquet, F. Bertin, X. Plainard, M.-J. Cornuejols, A. Maubon, Pierre Marquet, F. Saint Marcoux
Publikováno v:
Human Reproduction
Human Reproduction, Oxford University Press (OUP), 2011, 26 (11), pp.3028-36. ⟨10.1093/humrep/der288⟩
Human Reproduction, Oxford University Press (OUP), 2011, 26 (11), pp.3028-36. ⟨10.1093/humrep/der288⟩
International audience; BACKGROUND: We investigated a novel allotransplantation model using an aortocava patch in ewes. METHODS AND RESULTS: We carried out 10 uterine orthotopic allotransplantations in ewes with end-to-side anastomosis of the aortoca
Autor:
Franck Carbonnel, G. Piton, A. C. Dupont-Gossart, Georges Mantion, G. Herbein, G. Viennet, Audrey Weber
Publikováno v:
Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology
Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology, Elsevier Masson, 2008, 32 (5 Pt 1), pp.460-4. ⟨10.1016/j.gcb.2007.10.010⟩
Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology, Elsevier Masson, 2008, 32 (5 Pt 1), pp.460-4. ⟨10.1016/j.gcb.2007.10.010⟩
International audience; CMV reactivation is frequently observed in acute flares of ulcerative colitis (UC), particularly those which do not respond to intravenous steroids. Several recent series have suggested that, in most cases, CMV reactivation do
Autor:
Pierre Merville, Marie-Christine Moal, Jacques Dantal, Christophe Legendre, Nassim Kamar, Stéphane Quéré, Jean Philippe Rerolle, Bruno Moulin, Fabienne Di Giambattista, Laetitia Albano, Rachel Tetaz, Olivier Toupance, Arara Terpereau, Eric Alamartine
Publikováno v:
Annals of Transplantation
Annals of Transplantation, Springer Verlag (Germany), 2014, 17 (1), pp.58-67
Annals of Transplantation, 2014, 17 (1), pp.58-67
Annals of Transplantation, Springer Verlag (Germany), 2014, 17 (1), pp.58-67
Annals of Transplantation, 2014, 17 (1), pp.58-67
International audience; BACKGROUND: Data in kidney transplant recipients regarding elimination of calcineurin inhibitor (CNI) therapy from a de novo regimen based on low CNI exposure and an mTOR inhibitor are sparse, and restricted to CNI elimination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc0357f0eb3b9d101e32831b851411ba
http://www.hal.inserm.fr/inserm-00925721
http://www.hal.inserm.fr/inserm-00925721
Autor:
Rachel Chapot, Renée Ventura-Clapier, André Peinnequin, Bernard Serrurier, Hélène Richard, Valérie Novel-Chaté, Xavier Bigard, Nathalie Koulmann, Nadine Simler
Publikováno v:
American Journal of Respiratory and Critical Care Medicine
American Journal of Respiratory and Critical Care Medicine, American Thoracic Society, 2006, 174 (6), pp.699-705. ⟨10.1164/rccm.200512-1976OC⟩
American Journal of Respiratory and Critical Care Medicine, American Thoracic Society, 2006, 174 (6), pp.699-705. ⟨10.1164/rccm.200512-1976OC⟩
International audience; RATIONALE: Hypoxia-induced pulmonary hypertension involves hypoxia-inducible factor-1alpha (HIF-1alpha) activation as well as elevated resting calcium levels. Cyclosporin A (CsA) inhibits calcium-induced calcineurin activation
Autor:
Olivier Moralès, Nadira Delhem, Yvan de Launoit, Véronique Pancré, Céline Miroux, Filomena Conti, Khaldoun Ghazal, Samia Ben Othman
Publikováno v:
Transplantation
Transplantation, 2012, 94 (2), pp.123-31. ⟨10.1097/TP.0b013e3182590d8f⟩
Transplantation, Lippincott, Williams & Wilkins, 2012, 94 (2), pp.123-31. 〈10.1097/TP.0b013e3182590d8f〉
Transplantation, Lippincott, Williams & Wilkins, 2012, 94 (2), pp.123-31. ⟨10.1097/TP.0b013e3182590d8f⟩
Transplantation, Lippincott, Williams & Wilkins, 2012, 94 (2), pp.123-131. ⟨10.1097/TP.0b013e3182590d8f⟩
Transplantation, 2012, 94 (2), pp.123-31. ⟨10.1097/TP.0b013e3182590d8f⟩
Transplantation, Lippincott, Williams & Wilkins, 2012, 94 (2), pp.123-31. 〈10.1097/TP.0b013e3182590d8f〉
Transplantation, Lippincott, Williams & Wilkins, 2012, 94 (2), pp.123-31. ⟨10.1097/TP.0b013e3182590d8f⟩
Transplantation, Lippincott, Williams & Wilkins, 2012, 94 (2), pp.123-131. ⟨10.1097/TP.0b013e3182590d8f⟩
International audience; BACKGROUND: Liver transplantation is the treatment of end-stage liver diseases, including hepatitis C. Immunosuppression prevents graft rejection but seems to accelerate the recurrence of hepatitis C. Regulatory T cells (Tregs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1369a0a3992dac7abd57361a290b4e4c
https://hal.science/hal-00785885
https://hal.science/hal-00785885
Autor:
Isabelle Etienne, Pierre-François Westeel, Thierry Frouget, Yvon Lebranchu, B. Hurault de Ligny, Jean-Philippe Rerolle, Etienne Thervet, Antoine Thierry, Sandrine Girardot-Seguin, Bruno Moulin, Olivier Toupance, Mathias Büchler
Publikováno v:
American Journal of Transplantation
American Journal of Transplantation, 2011, 11 (8), pp.1665-75. ⟨10.1111/j.1600-6143.2011.03637.x⟩
American Journal of Transplantation, Wiley, 2011, 11 (8), pp.1665-75. ⟨10.1111/j.1600-6143.2011.03637.x⟩
American Journal of Transplantation, Wiley, 2011, 11 (8), pp.1665-75. 〈10.1111/j.1600-6143.2011.03637.x〉
American Journal of Transplantation, 2011, 11 (8), pp.1665-75. ⟨10.1111/j.1600-6143.2011.03637.x⟩
American Journal of Transplantation, Wiley, 2011, 11 (8), pp.1665-75. ⟨10.1111/j.1600-6143.2011.03637.x⟩
American Journal of Transplantation, Wiley, 2011, 11 (8), pp.1665-75. 〈10.1111/j.1600-6143.2011.03637.x〉
International audience; Calcineurin inhibitor (CNI) withdrawal has been used as a strategy to improve renal allograft function. We previously reported that conversion from cyclosporine A (CsA) to sirolimus (SRL) 3 months after transplantation signifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a6de94d50a9ce4a7b45d3a3ff29ebc2
https://www.hal.inserm.fr/inserm-00926380
https://www.hal.inserm.fr/inserm-00926380
Autor:
Woillard, Jean-Baptiste, Lebreton, Vincent, Neely, Michael, Turlure, Pascal, Girault, Stéphane, Debord, Jean, Marquet, Pierre, Saint-Marcoux, Franck
Publikováno v:
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, Wiley, 2014, 78 (4), pp.836-46. ⟨10.1111/bcp.12394⟩
British Journal of Clinical Pharmacology, 2014, 78 (4), pp.836-46. ⟨10.1111/bcp.12394⟩
British Journal of Clinical Pharmacology, Wiley, 2014, 78 (4), pp.836-46. ⟨10.1111/bcp.12394⟩
British Journal of Clinical Pharmacology, 2014, 78 (4), pp.836-46. ⟨10.1111/bcp.12394⟩
International audience; Ciclosporin A (CsA) is used in the prophylaxis and treatment of acute and chronic graft vs. host disease after haematopoietic stem cell (HSCT) transplantation. Our objective was to build and compare three independent Bayesian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::011fde89da5a2b4aec419637d95b14d9
https://www.hal.inserm.fr/inserm-00965397/file/clean_publi_ciclo_moelle_070314_rev1_corFSM_.pdf
https://www.hal.inserm.fr/inserm-00965397/file/clean_publi_ciclo_moelle_070314_rev1_corFSM_.pdf